BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Argus Health
Fish and Richardson

Generated: December 13, 2017

DrugPatentWatch Database Preview

Details for Patent: 5,514,646

« Back to Dashboard

Summary for Patent: 5,514,646

Title: Insulin analogs modified at position 29 of the B chain
Abstract:Analogs of human insulin modified at position 29 of the B chain thereof and, optionally, at other positions, have modified physico-chemical and pharmacokinetic properties and are useful in the treatment of hyperglycemia.
Inventor(s): Chance; Ronald E. (Westfield, IN), DiMarchi; Richard D. (Carmel, IN), Frank; Bruce H. (Indianapolis, IN), Shields; James E. (Noblesville, IN)
Application Number:08/057,201
Patent Claim Types:
see list of patent claims
Compound; Use; Composition;

No matches for this query

International Patent Family for Patent: 5,514,646

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office0383472► SubscribeSPC/GB96/036United Kingdom► Subscribe
European Patent Office0383472► Subscribe96C0040Belgium► Subscribe
European Patent Office0383472► SubscribeC960026Netherlands► Subscribe
Denmark0678522► Subscribe
Canada2009579► Subscribe
China1044820► Subscribe
China1034080► Subscribe
China1148984► Subscribe
China1103602► Subscribe
Cyprus1911► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Queensland Health
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: